ArticleTherapeutic advances in ophthalmology
Repurposing Alzheimer's disease medications-systemic cholinesterase inhibitors-for the treatment of dry eye syndrome, glaucoma, and age-related macular degeneration.
Shilpa Rajagopal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.